EvolveImmune Therapeutics reports that Ian Taylor, PhD, has joined its board of directors. Dr. Taylor is a veteran biopharma executive who currently serves as the chief scientific officer of Arvinas, where he manages all aspects of drug discovery research for a portfolio of novel cancer and neuroscience therapeutics … more
CytoVeris reports that Henry Couture has joined the company as Director of Quality. Mr. Couture has an extensive background with over 20 years of experience leading quality and safety initiatives. He will further develop CytoVeris’ quality system and ensure compliance as the company readies itself for FDA approval of its first medical device … more